Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Roivant Sciences Ltd.

Get SEC filing alerts via email and in your feed for Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

About Roivant Sciences Ltd.

Roivant Sciences Ltd. is a biopharmaceutical company focused on accelerating the development and commercialization of innovative medicines across multiple therapeutic areas. Its core strategy involves creating specialized subsidiaries, or "Vants," to develop targeted treatments for autoimmune, inflammatory, and rare diseases. Roivant leverages technology, strategic licensing, and a diversified pipeline to deliver therapies addressing high unmet medical needs globally.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Roivant Sciences Ltd.

1
1
Roivant Sciences Ltd. Roivant Sciences Reports $397.9 Million Net Loss for Fiscal Year 2026

Via official filing (AI summary) | 15 days ago | 0 comments

2
1
Roivant Sciences Ltd. Roivant Sciences Reports 78% Revenue Decline and $265.9M Net Loss for Q3 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Roivant Sciences Ltd. Roivant Sciences Reports Significant Revenue Decline and Improved Net Loss in Q2 FY 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Roivant Sciences Ltd. Roivant Sciences Reports Significant Revenue Decline and Increased Net Loss for Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Roivant Sciences Ltd. Roivant Sciences Reports $172 Million Net Loss for Fiscal Year 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Roivant Sciences Ltd. Roivant Sciences Reports Decline in Revenue and Net Income for December 2024 Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Roivant Sciences Ltd. Roivant Sciences Reports Revenue Growth, Increased Expenses, and Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments